Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1.

Clinical and investigative medicine. Medecine clinique et experimentale - 1 Jun 1994

Smith M, Salomon H, Wainberg M A

Abstract excerpt

Nucleoside antagonists of human immunodeficiency virus (HIV) reverse transcriptase (RT) activity have been commonly used in the therapy of HIV-associated disease. The prolonged use of such drugs has led to the development of HIV variants that display resistance against these compounds. HIV drug resistance has been documented clinically for each of the following nucleosides: 3'-azido-3'-deoxythymidine (AZT;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nucleosides
Share to Acquired Immunodeficiency Syndrome

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to Drug Resistance

Share to HIV Reverse Transcriptase

Share to Mutation

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 7523016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1.PMID 7523016Read ↗

[Molecular basis and clinical significance of HIV-1 resistance to nucleoside compounds].Semantic proximity Read ↗

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.Semantic proximity Read ↗

In vitro study of resistance-associated genotypic mutations to nucleoside analogs.Semantic proximity Read ↗

Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.Semantic proximity Read ↗

Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2Semantic proximity Read ↗

Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.Semantic proximity Read ↗

Clinical implications of resistance to antiretroviral drugs.Semantic proximity Read ↗

3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.Semantic proximity Read ↗

Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance.Semantic proximity Read ↗

Antiviral drug resistance.Semantic proximity Read ↗

HIV-1 drug resistance. Molecular pathogenesis and laboratory monitoring.Semantic proximity Read ↗

3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.